Synthetic THC Drug Approval in USA! Read Why is This Possible
The Drug Enforcement Administration has just recently approved THC Drug or Syndros. A pharmaceutical company, Insys Therapeutics DEVELOPED this cannabis based medication.
This medication is in fact a synthetic formulation of THC. People use it to treat vomiting and nausea. Those are the two most common symptoms of chemotherapy. FDA pre-approved this drug last summer as a treatment for vomiting, nausea, and weight loss in AIDS and cancer patients. The DEA approval places Syndros and its generic formulations in Schedule II of the Controlled Substance Act, indicating a “high potential for abuse”. Other Schedule II drugs include morphine, cocaine and many prescription painkillers.
The THC Drug
Last September the company Insys donated $500,000 to help defeat cannabis legalization campaign in Arizona. Yet now the company has just received the approval of DEA for its own drug based on cannabis. During the campaign, the company claimed to oppose the measure for legalization. The explanation was because it would fail to protect the safety of citizens and children in Arizona. Now, users of non-medical cannabis in Arizona must additionally face felony charges because they possess even the smallest amounts of the plant.
While Insys may insist that safety is their biggest concern, their aggressive marketing strategies for THC Drug or Subsys, a medication containing fentanyl. It is a dangerously powerful and addictive opiate that can be 50-100 times more powerful than Morphine, say otherwise.
It seems like the company is actually attempting to kill a non-pharmaceutical market for marijuana. The purpose is to fill their own pockets. Not actually considering the well-being or health of all people.
It seems clear that in a world where everyone could cultivate and use their own medicine, giant pharmaceutical companies such as Insys would inevitably lose a lot of revenue.
With more and more Americans succumbing to prescription opiate overdoses each year, there remains to be zero recorded deaths contributed to other-consumption of cannabis.